SMR, OKLO, CCJ: AI Power Meets the Nuclear Renaissance

BNP Paribas pivoted its top-decile fund into SMR-cohort stocks as institutional capital arrives. AI power demand and SMR commercialization timelines align.

The SMR AI power demand nuclear renaissance is no longer a futures-only story. On June 3, 2026, Bloomberg reported that a BNP Paribas Asset Management fund — beating 97% of peers over the past year — pivoted aggressively into small modular reactor stocks after a brief selloff. The signal matters less than the timing: it places institutional capital allocation onto an industry that has been waiting two decades for its commercialization window, and the window now aligns precisely with hyperscaler AI power demand through 2030.

What happened

BNP Paribas Asset Management's flagship AI-and-infrastructure focused fund disclosed that it had rotated meaningfully into SMR (NuScale Power), OKLO, and adjacent nuclear-fuel names following a 6-8% pullback in late May. Bloomberg's reporting cites the fund's view that SMR commercialization timelines and AI data center power requirements have entered a "first true overlap" zone for 2026-2030.

The same week, SoftBank announced plans to build 3.1 GW of AI data centers in the Hauts-de-France region by 2031 — a single commitment equivalent to the entire installed nuclear capacity of Pakistan. This is the contextualizing macro: AI-driven data center power demand is no longer a forecast, it is a deployed commitment that needs grid capacity now.

Why it matters for the AI power thesis

Three converging forces make the SMR cohort uniquely positioned through 2030:

  1. Hyperscaler AI power demand. Public capex schedules from Microsoft, Google, Amazon, and Meta imply incremental US data center electricity demand of 80-120 TWh by 2030 — roughly equivalent to powering 6-10 million homes. Conventional grid capacity additions cannot meet this in time.
  2. SMR commercialization window. NuScale (SMR) has received NRC design certification (the first SMR design to do so); Oklo (OKLO) has Idaho National Lab siting; BWX Technologies (BWXT) is already the dominant US naval nuclear supplier. The 2026-2030 window is the first time SMR commercial deployment and AI power demand intersect.
  3. Uranium fuel cycle bottleneck. Centrus Energy (LEU) holds the only US HALEU (High-Assay Low-Enriched Uranium) production license — required for most advanced SMR designs. Cameco (CCJ) is the largest non-Russian uranium miner. Both are scarcity plays on the fuel side. All three are needed for a complete thesis.

Data points

drillr-terminal snapshot fundamentals as of June 2, 2026:

MetricSMROKLOLEUBWXTCCJ
Market cap$4.8B$12.8B$3.9B$17.2B$52.5B
Current price$13.96$73.47$199.13$187.26$120.51
Forward P/S29.5x1,151x8.1x4.5x28.7x
Forward revenue growth+776%n/a+6.6%+14.0%-28.5%
EBITDA margin (TTM)n/mn/m16.1%16.1%31.0%
FCF margin (TTM)n/mn/m-13.6%9.7%25.4%
YTD price return-1.6%+2.4%-18.0%+8.3%+31.7%
1-year price return-56.1%+47.6%+51.5%+45.9%+101.9%

The valuation dispersion is the central feature of the cohort. SMR and OKLO trade as pre-revenue commercialization options (forward P/S effectively meaningless until commercial revenue lands); LEU and BWXT are operating businesses with cyclical exposure; CCJ is a mature commodity producer with miner economics.

The June 2 trading action is informative. CCJ closed at $120.51 — up 7.0% on the day. OKLO closed at $73.47, up 9.8%. SMR closed at $13.96, up 8.3%. LEU was up 5.4% at $199.13. Four of the five names moved together with magnitude consistent with thematic flow rather than idiosyncratic news. The dispersion between CCJ (+101.9% one-year) and SMR (-56.1% one-year) shows the cohort is still sorting out which businesses are pre-commercialization optionality versus already-monetized production.

CCJ stands out as the only cohort member with positive earnings consistency: EBITDA margin 31.0%, FCF margin 25.4%, FY 2025 revenue $607M. BWXT is the second operating profitable name (EBITDA margin 16.1%, +14% forward growth), supplying naval nuclear reactors and SMR component manufacturing. LEU's HALEU monopoly position is the most strategic asset in the cohort but currently runs at negative free cash flow as production scales.

Analysis: pricing the cohort over the 2026-2030 window

Three scenarios for the SMR AI power demand nuclear renaissance over the next 36 months:

Scenario A — Commercial first-megawatt by 2028. NuScale (SMR) achieves first commercial deployment in 2028 via a utility partnership; Oklo (OKLO) follows in 2029. Both names re-rate to multi-billion dollar revenue runs; BWXT supplies major component value; LEU's HALEU production scales to meet first wave demand; CCJ benefits from uranium price re-rating. Cohort gains 80-120% over the period.

Scenario B — Permitting delays push first commercial to 2030+. Common SMR risk factor. CCJ and BWXT — the operating businesses — outperform; SMR and OKLO compress as commercialization milestones slip. LEU benefits from incremental delay (additional HALEU demand for advanced designs). Cohort dispersion widens.

Scenario C — Hyperscaler capex slowdown. AI capex enters digestion phase late 2027. SMR-cohort thematic flows reverse. CCJ (operating mining business) holds up best; SMR and OKLO drop 30-50%; LEU sustains because HALEU is required regardless of commercial SMR timing. BWXT defended by Navy contracts.

The institutional positioning signal from the BNP fund pivot is the kind of allocation move that historically precedes thematic capital flows. Specialist nuclear-focused funds like Sprott Physical Uranium Trust and Global X Uranium ETF (URA) typically see net inflows for 4-8 weeks after a large-fund pivot becomes public knowledge.

The forward revenue growth divergence (SMR +776% on tiny base, OKLO no consensus, LEU +6.6%, BWXT +14%, CCJ -28.5%) tells the story of where the consensus is anchored. SMR/OKLO consensus reflects the commercial-deployment hopes; CCJ consensus reflects mid-cycle uranium price normalization. The asymmetry favors Scenario A: if commercial SMR deployment lands by 2028, CCJ consensus is materially too low.

What to watch

  • Q3 2026 NuScale (SMR) utility partnership signings: Any signed power purchase agreement with a Tier-1 utility re-rates the entire cohort.
  • Late 2026 / early 2027 Oklo Idaho National Lab milestone: Initial fuel load timeline for the Aurora reactor.
  • 2027 Centrus Energy (LEU) HALEU production target: 900 kg/year initial production; any beat re-rates LEU as the fuel-cycle choke point.
  • BWXT (BWXT) defense and SMR component orders: Quarterly bookings disclosure — the most boring but most reliable indicator in the cohort.
  • Cameco (CCJ) uranium price realization: Spot uranium has been range-bound $75-90/lb; any move above $100 triggers cohort-wide re-rating.
  • AI capex execution rate from hyperscalers: MSFT, GOOGL, AMZN, META quarterly capex prints. Any deceleration first hits SMR-thematic flows.

The SMR AI power demand nuclear renaissance is the rare thematic where institutional allocation, commercialization timing, and macro power demand have aligned in the same 4-year window. Cohort positioning has begun pricing this in; over the next 12-18 months, the trade resolves on commercial milestones rather than narrative momentum.


Try drillr.ai's terminal for SMR-cohort fundamentals, uranium spot price tracking, and hyperscaler capex schedules across the AI power demand stack.

Want to dig deeper into this analysis?

Drillr can make mistakes. Information only — not investment advice. Learn more